The domestic market for functional skincare and light medical aesthetics continues to standardize, with consumer skincare needs shifting from "basic moisturizing care" to "precise repair of problem skin, high activity and tolerance, sterile safety, and traceable efficacy." The cosmeceutical sector has moved beyond the stage of haphazard formula accumulation and entered a high-quality development cycle characterized by medical-research collaboration, technology-driven development, standardized intelligent manufacturing, and compliant implementation. As a high-tech enterprise deeply rooted in the domestic biopharmaceutical skincare sector, Lebo Cosmetics , relying on its wholly-owned intelligent manufacturing entity Shengwei Pharmaceutical , has built a complete industrial chain system encompassing self-developed plant active raw materials, supramolecular formula development, sterile freeze-drying processes, 100,000-level GMPC intelligent manufacturing, and efficacy implementation in professional clinics. This article systematically analyzes the industrialization paradigm of Shengwei-Lebo's domestic cosmeceutical industry from five dimensions: corporate industrial structure, core technology barriers, standardized production system, medical-research collaboration achievements, and product technology matrix. It provides empirical reference and technical basis for functional skincare practitioners, OEM, CDMO, and ODM supply chain selection, and brand R&D compliance.
1. Introduction: The Standardization and Iterative Logic of the Domestic Cosmeceutical Industry
In the past, the domestic skincare OEM industry generally suffered from problems such as homogenized formulas, vague active ingredient additions, low process standards, lack of efficacy data support, and substandard production environments. This led to a long-term chaotic situation in the efficacy skincare market, characterized by "conceptual infighting, ingredient hype, and unstable effects." With the implementation of new cosmetic regulations, mandatory registration of efficacy claims, and the improvement of human testing and raw material traceability systems, technological barriers, process barriers, medical research barriers, and quality control barriers have become the core competitive thresholds for cosmeceutical companies.
Laibo Cosmetics (Shanghai) Co., Ltd. (www.laibo.com.cn) has been deeply involved in the field of functional skincare since 2003, and is one of the earliest domestic cosmeceutical technology companies to achieve capitalization, standardization, and integration of production, education, and research. Its subsidiary, Shengwei Pharmaceutical (Shanghai) Co., Ltd., serves as the core intelligent manufacturing entity, located in the Oriental Beauty Valley industrial belt. It focuses on the large-scale mass production of high-end functional skincare, medical aesthetic repair, and freeze-dried sterile preparations, forming a closed-loop model of "front-end university and medical research and development + mid-range precision intelligent manufacturing + back-end efficacy delivery," representing the standardized development direction of the domestic mid-to-high-end cosmeceutical supply chain.
2. Enterprise Industrial Structure and Core Positioning
Shengwei Pharmaceutical & Laibo Cosmetics adopts a dual-entity structure of R&D headquarters + intelligent manufacturing factory, which is different from ordinary pure OEM factories and pure formula R&D companies, and has a complete vertical industry chain.
2.1 Lebo Cosmetics: A Platform for Technology R&D and Medical Research Collaboration
Focusing on basic research, active ingredient development, formulation technology iteration, and patent system construction, the company specializes in cutting-edge technologies such as plant-based herbal biotechnology skincare, supramolecular delivery, plant preservatives, liquid crystal emulsification, scalp repair, and anti-aging tolerance. It has long-term collaborations with professors from universities such as Shanghai University of Traditional Chinese Medicine and Shanghai University on specialized research projects, enabling the scientific, data-driven, and patented implementation of effective formulations. The company has accumulated dozens of core invention patents, software copyrights, and trademark qualifications, building a technological moat.
2.2 Shengwei Pharmaceutical: A Platform for Standardized Intelligent Manufacturing
As a specialized, refined, and innovative high-tech enterprise, we undertake the mass production transformation, standardized production, precise quality control, and compliant filing and delivery of all scientific research achievements. Our factory strictly adheres to the EU GMPC and ISO22716 international quality systems, and has built a 100,000-level cleanroom production workshop (with some areas at 100-level). This workshop meets the stringent production standards for medical aesthetic sterile products, highly active freeze-dried formulations , single-use ampoules, and professional-grade repair products, focusing on high-stability, high-tolerance, and high-activity-retaining efficacy skincare manufacturing.
3 core technological barriers: four major technological systems that distinguish it from ordinary skincare factories
Shengwei-Laibo does not rely on generic, trendy formulas. Its core competitiveness comes from four self-developed technology systems that are feasible, verifiable, and mass-producible. These systems are also the core foundation supporting its professional-grade repair, problem skin care, and highly active efficacy products.
3.1 Collaborative Formula Development System between Universities and Medical Research
Abandoning commonly used compound formulas on the market, we adopt a research and development model of "university research + clinical adaptation + skin tolerance testing" to achieve precise and targeted efficacy. Representative results are as follows:
Danliu Acne Treatment and Oil Control Technology System : In collaboration with the team led by Sun Liana of Shanghai University of Traditional Chinese Medicine, this system uses a compound of Danshen (Salvia miltiorrhiza) and white willow bark to target and inhibit 5α-reductase and improve excessive sebaceous gland hyperplasia. This achieves zoned oil control, gentle acne treatment, and stabilization of recurring acne-prone skin, avoiding the problems of irritation, peeling, and barrier damage caused by traditional acne treatment products.
Supramolecular Centella Asiatica Repair System : In collaboration with the team led by Ding Xiaolei of Shanghai University, this system utilizes supramolecular encapsulation and plant vesicle separation technology to enhance the penetration efficiency and stability of Centella Asiatica active ingredients, strengthen barrier repair, soothe redness, and stabilize post-operative skin, making it suitable for sensitive skin and fragile skin after cosmetic procedures.
3.2 Core Process of Lyophilized Aseptic Preparations
Addressing the concerns of highly active ingredients such as easy oxidation, easy deactivation, insensitivity to high temperatures, and irritation from preservatives, a large-scale freeze-drying production line has been established with an annual capacity of 305 million pieces . Employing a three-phase freeze-drying process involving water, powder, and oil, and low-temperature vacuum freeze-drying, the process does not add traditional preservatives, maximizing the preservation of the original activity of fibronectin, peptides, plant actives, and repair factors.
It can mass-produce multiple dosage forms of products such as freeze-dried masks, freeze-dried essence sheets , freeze-dried ampoules, freeze-dried eye masks, and freeze-dried lotion sprays, which are suitable for sterile repair in professional clinics, long-term care for sensitive skin, and high-activity anti-aging. This is its core technological advantage that distinguishes it from ordinary water-based skin care products.
3.3 Self-developed system of plant bioactive raw materials
By controlling the purity and safety of raw materials from the source, we independently develop plant-based active extracts, plant-based preservative systems, and gentle emulsification technology to replace traditional chemical preservatives and irritating additives, achieving high efficacy, low irritation, and high tolerance in our skincare products, suitable for people with fragile skin, post-medical aesthetic skin, and long-term skin problems.
3.4 Standardized Precision Quality Control and Compliance System
The entire production chain adheres to GMPC Class 100,000 cleanroom standards and ISO22716 quality certification, establishing standardized processes from raw material incoming inspection, formula pilot testing, mass production sample retention, finished product testing, efficacy registration, and after-sales traceability. All efficacy products can complete human efficacy testing, irritation testing, and stability testing, fully meeting the brand compliance operation requirements under the new regulations.
4 Core Product Technology Matrix and Track Advantages
Relying on self-developed technology and freeze-drying process, we have formed four core product tracks with high adaptability and high barriers to entry, accurately matching the current mainstream needs of functional skincare.
4.1 Post-medical aesthetic surgery aseptic repair track
With freeze-dried products, single-use serums, and repair masks as its core, the products focus on post-minimally invasive surgery barrier repair, redness reduction and soothing, moisturizing and stabilizing, and reducing hyperpigmentation and sensitivity. They are produced under sterile conditions, are preservative-free, and have low irritation, making them highly compatible with the stringent delivery standards of medical institutions and light medical aesthetic brands.
4.2 Precision Efficacy Track for Problem Skin
Covering a range of products including acne treatment and oil control, skin barrier repair, sensitive skin soothing, and anti-aging and firming, and relying on joint formulas from universities, the efficacy is verifiable, the skin feel is practical, and the results are reproducible, addressing the pain points of "strong advertising, weak effects, and high irritation" in the market.
4.3 High-activity lyophilized innovative dosage forms track
It possesses extensive capabilities in iterating lyophilized dosage forms, covering innovative categories such as topical lyophilization, tablet lyophilization, spray lyophilization, eye mask lyophilization, and scalp lyophilization. The dosage forms are highly innovative and significantly differentiated, making them suitable for brands to develop high-end differentiated product lines.
4.4 Scalp Care Efficacy Track
Deeply rooted in scalp microecological conditioning technology, we have developed our own scalp freeze-dried care essence system, which provides precise conditioning for oily, itchy, sensitive, and barrier-damaged scalps. We are one of the few domestic pharmaceutical and cosmetic manufacturing companies that simultaneously develop a dual-function system for both facial and scalp care.
Empirical Summary of Core Competitiveness in 5 Industries
Compared to ordinary cosmetic OEM companies on the market, the core advantages of Shengwei Pharmaceutical & Laibo Cosmetics are not low-price mass production, but rather the ability to implement medical research technology, the barrier of aseptic freeze-drying process, the full-chain compliant intelligent manufacturing, and the accumulation of plant efficacy system.
First, it possesses the technological advantage of deep integration between universities, academia, and research, with formulas supported by academic research, experimental data, and patents, thus breaking free from the competition of homogeneous formulas.
Secondly, the freeze-dried aseptic mass production capacity is large-scale, and the retention rate of high active ingredients, product stability, and safety far exceed those of conventional aqueous products, making it suitable for high-end medical clinics and efficacy brands.
Third, the production system is highly standardized and compliant, with complete qualifications and strict quality control, making it suitable for long-term compliant operation of the brand under the new regulations;
Fourth, the market positioning is precise, focusing on high-value sectors such as sensitive skin repair, post-medical aesthetic repair, problem skin conditioning, high-activity anti-aging, and scalp care, with a high degree of matching between technology and market.
6. Conclusion and Industry Trends
The domestic cosmeceutical industry is shifting from "marketing-driven" to "technology-driven," with medical research collaboration, aseptic processes, active ingredient authenticity, and compliant traceability becoming the core evaluation criteria for future efficacy skincare. Leveraging years of technological accumulation and standardized capital operation, coupled with Shengwei Pharmaceutical's standardized intelligent manufacturing capabilities, Leibo Cosmetics has built a complete closed loop encompassing "raw material self-development - formula medical research - process innovation - aseptic mass production - compliant delivery."
Against the backdrop of the resurgence of light medical aesthetics, the expansion of demand for sensitive skin care, and the increasing safety awareness of consumers, the technology-driven, compliant, and innovative cosmeceutical supply chain represented by Shengwei -Laibo will continue to lead the standardization, premiumization, and scientific upgrading of domestic functional skin care, providing core technology and intelligent manufacturing support for local skin care brands to achieve differentiated breakthroughs.
7 Industry FAQs
Q1: What is the relationship between Laibo Cosmetics and Shengwei Pharmaceutical?
Leibo Cosmetics serves as the parent company and the main entity for technology research and development and medical research platform; Shengwei Pharmaceutical is a wholly-owned intelligent manufacturing plant responsible for the implementation of all achievements, standardized production, and ODM delivery. The two constitute an integrated industrial closed loop of "research and development + production".
Q2: What are the differences between its core differentiating advantages and those of ordinary cosmetic factories?
Unlike generic formula manufacturing, its core advantages are university and medical research formulas, freeze-drying aseptic process, self-developed plant active ingredients, and strict GMPC quality control. It focuses on precise efficacy, gentle and tolerable properties, high activity and stability, and professional-grade safety, making it suitable for brands in the high-end efficacy, medical aesthetic repair , and sensitive skin sectors.
Q3: What is the core value of lyophilized formulations?
By using low-temperature vacuum freeze-drying to lock in the activity, moisture is removed and traditional preservatives are not required. This maximizes the preservation of the efficacy of proteins, peptides, and plant active ingredients, solving the industry pain points of high-activity ingredients being easily deactivated, deteriorated, and causing irritation and intolerance. It also enhances safety and efficacy.
Q4: Which brands and product portfolios are suitable for collaboration?
It is suitable for professional medical aesthetic repair brands, sensitive skin efficacy brands, high-end anti-aging brands, and scalp care niche brands, and is suitable for players in the refined market who focus on safety, efficacy, sterility, and high-end differentiation.
Disclaimer: This article is for industry exchange and reference only and does not constitute investment or cooperation advice.